Westchester Capital Management (New York)’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

Westchester Capital Management (New York)’s Portfolio KDNY Stock Details KDNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-559,062	Closed	-$21.5M	–	359
2023 Q2	$21.5M	Buy	+559,062	New	+$14.4M	0.68%	27

Westchester Capital Management (New York)'s KDNY Position: Q3 2023 in Review

Westchester Capital Management (New York) sold out of Chinook Therapeutics, Inc. Common Stock (KDNY) in Q3 2023, closing a stake of 559,062 shares — an estimated $21.5M sold.

Westchester Capital Management (New York) first reported a position in KDNY in Q2 2023 and held it in 1 quarter. The position peaked at $21.5M in Q2 2023. 2 funds tracked by Wall St. Rank hold KDNY as of Q3 2023.

Westchester Capital Management (New York) reported no remaining Chinook Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Westchester Capital Management (New York) sold 559,062 Chinook Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $21.5M.
Westchester Capital Management (New York) first reported a position in Chinook Therapeutics, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
Westchester Capital Management (New York)'s Chinook Therapeutics, Inc. Common Stock position peaked at $21.5M in Q2 2023.
2 funds tracked by Wall St. Rank held Chinook Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Westchester Capital Management (New York)'s 13F filing for Q3 2023, filed 8 Nov 2023.